Insider at Vertex Pharmaceuticals (VRTX) Makes Significant Sale of Stock

Wednesday, January 17, 2018 10:15 PM ET

Insider at Vertex Pharmaceuticals (VRTX) Makes Significant Sale of Stock

An insider — Dr David Altshuler, Officer — sold 56,250 shares of Vertex Pharmaceuticals having a market value of approximately $8,830,755 today, as indicated in a form 4 document filed with the SEC. There have been 8 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 301,417 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 357,667 shares and have averaged 39,741 shares per transaction over this time period.

The number of insider buy/sell trades at Vertex Pharmaceuticals is greater than that of the 280 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 330 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Vertex Pharmaceuticals insiders is lower than its peers. Within the peer group there were 44,055,200 shares purchased and 41,107,041 shares sold with company insiders purchasing 13,776 shares on average over this time period.

The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.